Why the study?
Does intensive glucose control reduce cardiovascular outcomes in patients with type 2 diabetes?
Does intensive glucose control reduce cardiovascular outcomes in patients with type 2 diabetes?
This review highlights the need for individualized glucose targets in type 2 diabetes, as intensive control does not universally reduce cardiovascular events and may increase hypoglycemia risk.
No takes yet. Share an insight, caveat, or question.
Does not support routine intensive control in type 2 diabetes; leaves open targeted use in select low-hypoglycemia-risk patients.
Giorgino et al. (2013) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: